Live Breaking News & Updates on Novel Innate Defense Regulator

Stay updated with breaking news from Novel innate defense regulator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease

Pipeline Expansion of Novel Innate Defense Regulator Technology
PRINCETON, N.J., Nov. 30, 2023 /PRNewswire/ Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and. ....

United Kingdom , B Brett Finlay , Christopherj Schaber , Robert Hancock , Development Authority , Exchange Commission , Biomedical Advanced Research , Our Public Health Solutions , Us Development , Us Congress , Prnewswire Soligenix Inc , University Of British Columbia , National Institute Of Allergy , Defense Threat Reduction Agency , Soligenix Inc , Drug Administration , Pipeline Expansion , Novel Innate Defense Regulator , Investigational New Drug , Aphthous Ulcers , Chief Executive Officer , British Columbia , Middle East , East Asia , Public Health Solutions , National Institute ,